MediLink's TMALIN ADC linker technology: Tumor microenvironment specific extracellular and intracellular double cleavage mechanism for better efficacy and …
用户UpvblTY_VnuA
4个月前
222
10
已完结
1. 系统已在2025-06-03 17:30:34对应助文件进行删除
2. 如有需要请重新发布求助信息
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
T Xue, L Xiao, Q Liu, S Song, A Shan, X Zhang…
Cancer …, 2024
aacrjournals.org
Antibody-drug conjugates (ADC) are a type of the fastest growing anticancer drug modalities. However, the traditional ADC technologies constrain on therapeutic development, requiring overexpressed targets, high internalizing antigens and efficient intracellular processing. To this end, MediLink
